Lauren Welch, Kammi Fox-Kay, and Cathy Simmons discuss their approaches to educating patients on the importance of waiting for biomarker testing before starting therapy for non–small cell lung cancer (NSCLC) to individualize therapy with the treatment that is best suited for their cancer and to achieve the best outcomes.
Video Library —June 8, 2021
Categories:
Interview with the InnovatorsThoracic Oncology Nurse Navigator
University of Chicago Medicine
Chicago, Illinois
University of Chicago Medicine
Chicago, Illinois
Thoracic Oncology Navigator
Sarah Cannon Cancer Institute
Plano, Texas
Sarah Cannon Cancer Institute
Plano, Texas
Nurse Practitioner
Tennessee Oncology
Nashville, TN
Tennessee Oncology
Nashville, TN
Last modified: November 15, 2022